This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.10, was awarded by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 0.5% ophthalmic solution, a medication commonly used to treat eye-related pain and inflammation.
The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of December 13, 2024. This award is not associated with a specific set-aside program, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/13/25, 10:06 AM